| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| aripiprazole lauroxil | alpha-1a adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | antagonist |
| aripiprazole lauroxil | alpha-1b adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | antagonist |
| aripiprazole lauroxil | alpha-2a adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | alpha-2b adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | alpha-2c adrenergic receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | muscarinic acetylcholine receptor m1 | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | muscarinic acetylcholine receptor m2 | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | muscarinic acetylcholine receptor m3 | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | muscarinic acetylcholine receptor m4 | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | muscarinic acetylcholine receptor m5 | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | dopamine d1 receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | dopamine d2 receptor | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.12 | approved,investigational | partial agonist |
| aripiprazole lauroxil | dopamine d3 receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | dopamine d4 receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | dopamine d5 receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | histamine h1 receptor | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | antagonist |
| aripiprazole lauroxil | 5-hydroxytryptamine receptor 1a | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.2 | approved,investigational | partial agonist |
| aripiprazole lauroxil | 5-hydroxytryptamine receptor 1b | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | 5-hydroxytryptamine receptor 1d | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | 5-hydroxytryptamine receptor 1e | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank , DGIDB | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.15 | approved,investigational | antagonist |
| aripiprazole lauroxil | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | 5-hydroxytryptamine receptor 3a | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | 5-hydroxytryptamine receptor 6 | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| aripiprazole lauroxil | 5-hydroxytryptamine receptor 7 | small molecule | NA | drugbank | Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | unknown |
| click here to return to the previous page | ||||||||